Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant paclitaxel + carboplatin plus sorafenib in advanced ovarian cancer with ascites
2006-004644-24Phase 2Terminated
- Sponsor
- University of Bonn
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sorafenib in ovarian cancer, sponsored by University of Bonn. Primary endpoint: Progression-free survival. Started Apr 2007; status: terminated.
02
Drugs
sorafenib
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on 2006-004644-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004644-24.